TickerFacts.

CytomX Therapeutics, Inc. (CTMX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.88M
Year ended 2018-12-31
+16.0%
3-year compound annual growth
+23.5%
5-year compound annual growth
2013-12-31: $655.0K2014-12-31: $783.0K2015-12-31: $1.21M2016-12-31: $1.73M2017-12-31: $1.65M2018-12-31: $1.88M$1.88M
2013-12-31 Depreciation & Amortization (USD) 2018-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2018-12-31$1.88M+14.5%2019-02-27, From 2018-01-01
2017-12-31$1.65M-5.1%2019-02-27, From 2017-01-01
2016-12-31$1.73M+43.7%2019-02-27, From 2016-01-01
2015-12-31$1.21M+54.0%2018-03-07, From 2015-01-01
2014-12-31$783.0K+19.5%2017-03-02, From 2014-01-01
2013-12-31$655.0Kn/a2016-03-07, From 2013-01-01